FIELD: chemistry.
SUBSTANCE: invention relates to a compound of formula (I), a separation material of formula (II), a column for extracorporeal removal of the C-reactive protein (CRP), and a device comprising same, which can be used in medicine: (I), (II), where b selected from 2 and 3; X selected from -SH, -NH2, -C≡CH, -CH=CH2, -N3 and -CHO; R1 and R2 selected from -CH3, -C2H5, -C3H7, -C4H9, -C5H11 and -C6H13, or R1 and R2 form, together with the nitrogen atom to which they are attached, a heterocycle selected from: , and , where the hydrogen atoms can be replaced by fluorine atoms; -L- in formula (I) selected from -(CH2)m-O-C(O)-NH-(CH2)p1-, -(CH2)m-O-(CH2)p1-, -(CH2)m-C(O)-NH-(CH2)p1-, -(CH2)m-NH-C(O)-(CH2)p1-, -(CH2)m-C(O)-NH-(CH2)n-O-(CH2)p1-, -(CH2)m-O-C(O)-NH-(CH2)n-O-(CH2)p1-, -(CH2)m-C(O)-NH-(CH2)n-C(O)-NH-(CH2)p1-O-(CH2)p2-, and -(CH2)m-O-C(O)-NH-(CH2)n-C(O)-NH-(CH2)p1-O-(CH2)p2-; m, n, p1, p2, o, r, q selected from 1, 2, 3, 4, 5, 6, 7, 8, 9, 10; Y selected from -CH(OH)-CH2-NH-, -CH(OH)-CH2-S-, -CH2-NH-, -NH-CH2-, -CH2-CH2-S-, -S-CH2-CH2-, , , , , , , and ; -L- in formula (II) selected from -La-, -La-Le-, -La-Lb-Le- and -La-Lb-Ld-Lc-Le-, where -La- selected from -(CH2)m-, -(CH2-CH2-O)m-CH2-; -Lb- and -Lc- selected from -O-, -NH-C(O)-, -C(O)- NH-, -O-C(O)- NH- and -SO2-; -Ld- selected from -(CH2)n-, -(CH2-CH2-O)n-CH2-; -Le- selected from -(CH2)p1-, -(CH2)p1-O-(CH2)p2-; -L*- selected from -L*a-, -L*a-L*e- and -L*a-L*b-L*e-, where -L*a- selected from -(CH2)o-, -(CH2-CH2-O)o-C2H4-, -(CH2-CH2-O)o-CH2- and -CH2-CH(OH)-CH2-; -L*e- selected from -(CH2)q-, -C2H4-(O-CH2-CH2)q-, and CH2-(O-CH2-CH2)q-; -L*b- selected from -O-(CH2)r-O-, -S-(CH2)r-S-, -SO2-, -S-, -O-, -NH-C(O)-, -C(O)-NH- and -S-S-; and A is a solid substrate of agarose and sepharose®.
EFFECT: novel compound, a novel separation material, a novel column and a device comprising same are disclosed for effective extracorporeal removal of CRP from a biological fluid for the prevention or treatment of immune dysfunctions and cardiovascular diseases.
9 cl, 27 ex, 1 tbl
Title | Year | Author | Number |
---|---|---|---|
SUCCINIC ACID DERIVATIVES, SUCCINIC ACID-POLYSACCHARIDE DERIVATIVE, METHOD OF PREPARING SUCCINIC ACID-GLYCOSAMINOGLYCANE DERIVATIVE, METHOD OF PREPARING SUCCINIC ACID-POLYAMINOSACCHARIDE DERIVATIVE, AND METHOD OF PREPARING CROSS- LINKED SUCCINIC ACID-POLYSACCHARIDE DERIVATIVE | 1995 |
|
RU2169136C2 |
DUAL-ACTING ANTIHYPERTENSIVE COMPOUNDS, METHODS FOR PREPARING THEM, BASED PHARMACEUTICAL COMPOSITIONS AND INTERMEDIATE COMPOUNDS | 2008 |
|
RU2476427C2 |
WATER-SOLUBLE ANALOGUES CC-1065 AND THEIR CONJUGATES | 2007 |
|
RU2489423C2 |
BILE ACID-SUBSTITUTED PHENYLALKENOYLGUANIDINES, MEDICINAL AGENT | 1999 |
|
RU2232769C2 |
CALICHEAMICIN DERIVATIVES AND THEIR ANTIBODY-DRUG CONJUGATES | 2018 |
|
RU2732568C1 |
MACROLIDES AND PHARMACEUTICAL COMPOSITION BASED ON THEREOF | 2000 |
|
RU2243230C2 |
QUINOLINE AND QUINOXALINE DERIVATIVES EFFECTIVE AS CYSTEINYL-LEUKOTRIENE ANTAGONISTS | 2012 |
|
RU2605929C2 |
PYRIDINONE DERIVATIVES AS TISSUE TRANSGLUTAMINASE INHIBITORS | 2013 |
|
RU2652987C2 |
SUBSTITUTED 2-OXY-QUINOLINE-3-CARBOXAMIDES AS KCNQ2/3 MODULATORS | 2011 |
|
RU2595894C2 |
STEROIDS THAT RELEASE NITROGEN OXIDE | 2008 |
|
RU2442790C2 |
Authors
Dates
2018-09-07—Published
2015-06-19—Filed